Novartis, Amgen join forces to fight Alzheimer's and migraine

LONDON (Reuters) - Novartis and Amgen are joining forces in the hunt for an Alzheimer's treatment, in the latest sign that drugmakers believe an effective therapy for the memory-robbing disease may be within reach.